Elevated circulating microRNA-210 levels in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: a potential new biomarker

By Zhang Qiuwang   Kandic Ivana   Faughnan Marie E.   Kutryk Michael J.  

Biomarkers, Vol. 18, Iss. 1, 2013-02 ,pp. : 23-29

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of colorectal cancer

By Mulcahy Mary F   Benson III Al B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab for the treatment of high-grade glioma

By Khasraw Mustafa   Simeonovic Marcelle   Grommes Christian  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1101-1111

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab

By Park Sung Chul   Su Daniel   Tello Celso  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1641-1647

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials

By Khasraw Mustafa   Ameratunga Malaka   Grommes Christian  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite